Tierney Saccavino | executive |
Ron Cohen | executive |
Michael Gesser | executive |
Welcome to Acorda Therapeutics' Third Quarter 2023 Financial and Business Update. [Operator Instructions] Please be advised that this call is being recorded at the company's request. I will now introduce your host for today's call, Tierney Saccavino with Acorda. Tierney, please go ahead.
Thank you, Cole, and good afternoon, everyone.
Before we begin, let me remind everyone that our presentation will contain forward-looking statements.